Home / Our Work / Grant Management / Commonwealth Partnerships for Antimicrobial Stewardship Scheme / CwPAMS programme extension
Hero image

Open call for grant applications for the extension to the CwPAMS programme

As announced at the CwPAMS Sharing and Learning event on 25th June, THET and CPA are pleased to announce a second round of grants under the Commonwealth Partnerships for Antimicrobial Stewardship Scheme (CwPAMS) with support from UK Department of Health and Social Care’s Fleming Fund.

Blue leaf
Blue leaf

The Programme

CwPAMS aims to leverage the expertise of UK health institutions and technical experts to strengthen the capacity of the national health workforce and institutions in Commonwealth countries to address antimicrobial resistance (AMR) challenges. More information on CwPAMS and the projects funded in the first round of the grant programme is available here.

Grants allocated under the CwPAMS extension should place a central focus on antimicrobial stewardship (AMS) and on developing pharmacy expertise and capacity whilst incorporating and expanding the findings from other infection prevention and control initiatives and strengthening capacity of using clinical microbiology data.

THET welcomes grant applications from Health Partnerships operating in the following 8 countries:

Ghana | Kenya | Malawi | Nigeria | Sierra Leone |
Tanzania | Uganda | Zambia

The Details

Funding Available and Application Details

Grants are available from £10,000 up to a maximum of £20,000. All funded projects are expected to last between 6 and 7 months. Project activities can be implemented from October 2021 until May 2022.

Funding will be available for:

1) ‘Start-up’ projects led by any Health Partnership, whether newly-formed or long established, as long as the two leads have not previously been awarded a CwPAMS grant together.

2) Projects led by existing CwPAMS partnerships to focus on initial steps that will pave the way for longer-term projects and build on previous work carried out.

Core Eligibility

All those considering applying should carefully read the eligibility and funding criteria contained in the Call for Applications and Q&A document as these may differ from previous THET grant streams.

How to Apply

Download and read all of the following documents:

The grant application form, budget template and AMS assessment tool should be completed and submitted, along with letters of support from each of the lead partner institution, in one email to grants@thet.org by noon (BST) on Thursday 2nd September 2021.

If you have questions or difficulty downloading or accessing any of the documents listed please email us at grants@thet.org

Further Details

Pre-application Webinar

THET and CPA delivered a pre-application webinar to run through the application process, project planning principles and the CwPAMS AMS assessment tool.

To catch up on the recording, please click here. 

To access the presentation, please click here.

New Partnerships

Those interested in forming a new Health Partnership, with the aim to submit an application to the CwPAMS extension programme, should complete the CwPAMS ‘Brokering new partnerships’ survey as soon as possible.

Our Partners

The Fleming Fund is a UK aid programme, helping low- and middle-income countries tackle antimicrobial resistance (AMR). Its aim is to improve the surveillance of AMR and generate relevant data that is shared nationally and globally.

The Commonwealth Pharmacists Association (CPA) is a UK-based charity that advances health, promotes well-being and improves medicines-related education and use for the benefit of the Commonwealth. By supporting the development of safe and effective systems of medicines management, maximising the skill level and encouraging the better utilization of the pharmacy workforce, the CPA seeks to encourage the optimisation of medicines and health-related advice given to the public, with the aim of improving health outcomes and reducing health inequalities throughout the Commonwealth.

Why Antimicrobial Resistance?

AMR poses a catastrophic threat to us all and yet until recently it has remained a neglected area of global health.

A number of factors can increase the spread of resistant microorganisms. For example, antimicrobial drugs are often used unnecessarily, which increases the risk that microorganisms can become resistant, survive and multiply. In 2016, 490,000 people developed multi-drug resistant TB, and drug resistance is starting to complicate the fight against HIV and malaria as well.

The independent Review on antimicrobial resistance estimated that,

at least 700,000 deaths each year globally are attributable to drug resistance to infections including bacterial infections, malaria and HIV/AIDS.

Unless action is taken, it is thought the burden of deaths from AMR could balloon to 10 million lives each year by 2050 and cost the global economy up to $100 trillion US Dollars.

It is estimated that 5000 deaths are already caused every year in the UK alone because antibiotics no longer work for some infections.

Rising drug resistance is a global hazard and if we do not tackle it, every day procedures such as caesarean sections, cancer therapy, and hip replacements will become extremely dangerous.

Antimicrobial resistance poses a catastrophic threat to us all and yet until recently it has remained a neglected area of global health. At THET we believe that working in partnerships is the best way to strengthen health systems both at home and overseas.

Ben Simms - CEO, THET

Hero image